Report on the 12th International Society of Blood Transfusion Platelet Immunology Workshop

被引:39
作者
Bessos, H
Wilson, DWL
Metcalfe, P
Allen, D
Urbaniak, SJ
机构
[1] Scottish Natl Blood Transfus Serv, Natl Sci Lab, Edinburgh EH17 7QT, Midlothian, Scotland
[2] Scottish Natl Blood Transfus Serv, Aberdeen, Scotland
[3] Natl Inst Biol Stand & Controls, Potters Bar, Herts, England
[4] Natl Blood Serv, Oxford, England
[5] Univ Aberdeen, Acad Transfus Med Unit, Aberdeen, Scotland
关键词
genotyping; ISBT; platelet antibodies; platelet antigens; platelet workshop;
D O I
10.1111/j.1423-0410.2005.00672.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Objectives The aims of the 12th International Society of Blood Transfusion (ISBT) Platelet Immunology Workshop were to evaluate the proficiency of molecular human platelet antigen (HPA) genotyping and detection of platelet antibodies of unusual specificity or reactivity, to assess whether quantification of anti-HPA-1a is practicable, and to determine the variability of reagents and components used in the monoclonal antibody immobilization of platelet antigens assay (MAIPA). Materials and Methods Forty participants from 23 countries were sent 10 samples for DNA typing, five samples for antibody detection, a freeze-dried anti-HPA-1a standard, three samples for anti-HPA-1a quantification and a MAIPA method questionnaire. Results The detection and identification of HPA antibodies varied from 2.7 to 95% of participants. The number of HPA genotyping errors per sample ranged from 0 to 3.96% per HPA loci. The majority of laboratories were able to assign an arbitrary number of units/ml of anti-HPA-1a activity to the unknown samples. The MAIPA questionnaire indicated a wide variation among participants, both in method and in reagents used. Conclusions The results obtained from this workshop highlighted deficiencies in testing regimes and identified a need for internationally available reference materials.
引用
收藏
页码:105 / 113
页数:9
相关论文
共 25 条
[1]  
ALLEN D, 2005, VOX SANG
[2]  
ALLEN DL, TRANSFUS MED, V6, P172
[3]   DNA typing of human platelet antigen systems 1, 2, 3 and 5 in B-lymphoblastoid cell lines of the International Histocompatibility Workshop [J].
Bein, G ;
Hackstein, H ;
Kluter, H .
TISSUE ANTIGENS, 1997, 49 (05) :443-447
[4]   Detection of Gov system antibodies by MAIPA reveals an immunogenicity similar to the HPA-5 alloantigens [J].
Berry, JE ;
Murphy, CM ;
Smith, GA ;
Ranasinghe, E ;
Finberg, R ;
Walton, J ;
Brown, J ;
Navarrete, C ;
Metcalfe, P ;
Ouwehand, WH .
BRITISH JOURNAL OF HAEMATOLOGY, 2000, 110 (03) :735-742
[5]   The management of alloimmune neonatal thrombocytopenia [J].
Blanchette, VS ;
Johnson, J ;
Rand, M .
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2000, 13 (03) :365-390
[6]   The fetal and neonatal consequences of maternal alloimmune thrombocytopenia [J].
Bussel, J ;
Kaplan, C .
BAILLIERES CLINICAL HAEMATOLOGY, 1998, 11 (02) :391-408
[7]   HPA genotyping by PCR sequence-specific priming (PCR-SSP): A streamlined method for rapid routine investigations [J].
Cavanagh, G ;
Dunn, AN ;
Chapman, CE ;
Metcalfe, P .
TRANSFUSION MEDICINE, 1997, 7 (01) :41-45
[8]   Human platelet antigen-specific alloantibodies implicated in 1162 cases of neonatal alloimmune thrombocytopenia [J].
Davoren, A ;
Curtis, BR ;
Aster, RH ;
McFarland, JG .
TRANSFUSION, 2004, 44 (08) :1220-1225
[9]  
Goldman M., 2003, Vox Sanguinis, V85, P149, DOI 10.1046/j.1423-0410.2003.00327.x
[10]   Severe neonatal alloimmune thrombocytopenia caused by antibodies to human platelet antigen 3a (Baka) detectable only in whole platelet assays [J].
Harrison, CR ;
Curtis, BR ;
McFarland, JG ;
Huff, RW ;
Aster, RH .
TRANSFUSION, 2003, 43 (10) :1398-1402